Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

icate superior protection when compared to similar viral challenge studies for competitive vaccine designs currently in human clinical trials. We are therefore very excited about the potential for our vaccine."

Dr. McNally continued, "On the financial side, we continue to benefit from NIH/HVTN support of our human clinical trials and we are seeking additional government support to fund our internal research and development activities to expand the use of our technology against strains (clades) of the HIV virus affecting other areas of the globe. From December 2011 to March 2012, we raised a total of $2.7 million in equity capital to bolster our cash reserves."

Comment on Gilead Science's Truvada® Prevention SubmissionDr. McNally also commented on the recent news related to an advisory panel's recommendation that the FDA approve Gilead Science's submission of their anti-viral medication, Truvada, for prevention of HIV. "While any positive step towards the control of this deadly disease is greatly welcomed, we must continue the search for safe, cost-effective measures to prevent HIV transmission. The high cost of oral medications, patient compliance, and risk of medical side effects clearly suggest the best solution still lies with a preventive vaccine. GeoVax's preventive vaccine is considered a leading candidate for the version of the virus prevalent in North and South America, and Europe."

Financial ReviewGeoVax reported a net loss for the three months ended March 31, 2012 of $730,513, or $0.04 per share, based on 16.7 million weighted average shares outstanding. For the three months ended March 31, 2011, the Company reported a loss of $606,282, or $0.04 per share, based on 15.7 million weighted average shares outstanding.

The Company reported revenues of $854,063 for the three months ended March 31, 2012, related to its Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institutes
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Fla. , July 2, 2015  Fort ... is pleased to announce that its Consumer Group ... Beverages") to Kerry Group plc (ISE: KRZ) ("Kerry"), ... taste and nutrition systems, as well as functional ... and pharmaceutical markets. Farlie Turner served as the ...
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ... Market by Analog, Application, End-User & by Region - Global ... This market is projected to reach about $2.5 ... different applications and rising opportunities in countries such as ... Italy , and Brazil . ...
(Date:7/2/2015)... 2015 Pharma Major Lupin Limited today ... in Russia subject to certain closing ... market which recorded RUB 765 billion in sales, placing it ... world in 2014 (IMS Health). For over a decade, Russian ... with this trend, projecting Russia to ...
Breaking Medicine Technology:Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US ... with even minimal asbestos exposure. Click here to read the complete story , ... Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice with ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Smoothies are all ... a good blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce ... an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Yisrayl Hawkins, ... new article this week that he says will reveal biblical truth and expose popular ... “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the core of ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on ... opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... out on the best drug treatment for their disease, because ... of print in the Archives of Disease in Childhood. ... and the disease prompts up to a third of children ... , The researchers used national data to calculate the number ...
... CINCINNATI, Sept. 3 Most children in the ... Attention Deficit,Hyperactivity Disorder (ADHD) have not been diagnosed ... medications, according to the first,national ADHD prevalence study ... criteria, according to a new study conducted by ...
... appears to be associated with adolescents risk of becoming ... in their lifetimes, according to a report in the ... one of the JAMA/Archives journals. , Previous studies have ... risk of starting to smoke, according to background information ...
... the medications they need, researchers say , , MONDAY, Sept. ... children have attention-deficit/hyperactivity disorder (ADHD), but only 32 percent ... That,s the sobering conclusion of a landmark new study, ... consider the "gold standard" of diagnostic criteria -- the ...
... Stent is Featured at ... ESC Congress 2007, ... from patient subsets of a global registry support,the use of the ... Presented today by Robbert de Winter, M.D., Ph.D., at the European,Society ...
... Cam in Cambridge, famous as a haunt of students ... become the next generation of antibiotics, according to scientists ... for General Microbiologys 161st Meeting at the University of ... With antibiotics now over-prescribed for treatments of bacterial infections, ...
Cached Medicine News:Health News:Childhood asthma still inappropriately treated in the UK 2Health News:Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New 'Gold Standard' Study by Cincinnati Children's Researchers 2Health News:Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New 'Gold Standard' Study by Cincinnati Children's Researchers 3Health News:Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New 'Gold Standard' Study by Cincinnati Children's Researchers 4Health News:Teens who see more smoking in movies may have increased risk of becoming established smokers 2Health News:9% of U.S. Kids Have ADHD 2Health News:9% of U.S. Kids Have ADHD 3Health News:Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents 2Health News:New viruses to treat bacterial diseases -- 'My enemies' enemy is my friend' 2
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
... Rochester Medical's line ... the intermittent catheters you ... All four product configurations ... and antibacterial hydro - ...
The Uro San® Plus male external catheter is a latex catheter with a double-sided adhesive and Shield Skin Protective Dressing....
... Rochester Medical's line ... the intermittent catheters you ... All four product configurations ... and antibacterial hydro - ...
Medicine Products: